Evaluation and Testing Services for Vaccines and Other Biologics for Infectious Diseases

The National Institutes of Health is seeking evaluation and testing services for vaccines and other biologics aimed at infectious diseases. This contract opportunity involves providing specialized scientific and laboratory services to assess the safety, efficacy, and quality of vaccine candidates and biologic products. It falls under the NAICS code 541714, which pertains to research and development in biotechnology. The focus is on advancing public health efforts by supporting the development and validation of medical countermeasures against infectious threats. Key points of contact for the contract include Lisa Wei as the program point of contact and Sharee Richardson as the contracting officer. Specific details about the place of performance and set-aside provisions are not provided. The solicitation is listed as a forecast opportunity, indicating anticipated contracting needs rather than an active solicitation, with the official announcement posted in March 2026. Interested parties can seek further information through the provided points of contact or visit the official opportunity page maintained by the NIH.